P

Pliant Therapeutics
D

PLRX

1.15000
USD
0.02
(1.77%)
مغلق
حجم التداول
23,583
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
71,210,182
المقالات
المزيد

العنوان: Pliant Therapeutics

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novelintegrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.